Provided by Tiger Trade Technology Pte. Ltd.

Biora Therapeutics, Inc.

0.2200
0.0000
Volume:- -
Turnover:- -
Market Cap:3.55M
PE:-0.02
High:0.2200
Open:0.2200
Low:0.2200
Close:0.2200
52wk High:0.2200
52wk Low:0.2200
Shares:16.12M
Float Shares:3.20M
Volume Ratio:3.53
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.4616
EPS(LYR):-78.6868
ROE:--
ROA:-154.63%
PB:-0.03
PE(LYR):0.00

Loading ...

Biora Therapeutics Files for Chapter 11, Secures $10.25 Million Financing for Sale Process

MT Newswires Live
·
Dec 30, 2024

Biora Therapeutics Files for Chapter 11 Bankruptcy

Dow Jones
·
Dec 30, 2024

Biora Therapeutics Inc - Secures up to $10.25 Million in Debtor in Possession Financing

THOMSON REUTERS
·
Dec 30, 2024

Biora Therapeutics Inc - to File Motion for Approval of Marketing and Sale Process

THOMSON REUTERS
·
Dec 30, 2024

Biora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future Growth

THOMSON REUTERS
·
Dec 30, 2024

Press Release: Biora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future Growth

Dow Jones
·
Dec 30, 2024

Biora Therapeutics Files for Chapter 11 Bankruptcy - Court Filing

THOMSON REUTERS
·
Dec 28, 2024

Biora Therapeutics Lists Estimated Assets Between $10 Mln to $50 Mln and Estimated Liabilities Between $100 Mln and $500 Mln - Court Filing

THOMSON REUTERS
·
Dec 28, 2024

Top Midday Decliners

MT Newswires Live
·
Dec 11, 2024

Dow Falls 150 Points; Oracle Posts Downbeat Results

Benzinga
·
Dec 10, 2024

Investors Look Ahead to Key Inflation Data as US Futures Tread Water in Tuesday's Premarket

MT Newswires Live
·
Dec 10, 2024

Biora Therapeutics Inc - Nasdaq to Delist Biora Therapeutics Due to Non-Compliance

THOMSON REUTERS
·
Dec 10, 2024

Biora Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Nov 19, 2024

Biora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Nov 15, 2024

Highbridge Capital Management, Llc Reports 9.99% Passive Stake in Biora Therapeutics Inc as of Sept 30, 2024- SEC Filing

THOMSON REUTERS
·
Nov 14, 2024

BRIEF-Biora Therapeutics Provides Corporate Update And Reports Third Quarter 2024 Financial Results

Reuters
·
Nov 14, 2024

Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

THOMSON REUTERS
·
Nov 14, 2024

Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview

Reuters
·
Nov 13, 2024

Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview

Reuters
·
Nov 08, 2024

Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update

THOMSON REUTERS
·
Nov 08, 2024